Immune response at birth, long-term immune memory and 2 years follow-up after in-utero anti-HBV DNA immunization

Gene Therapy

Volumn 11, Issue 6, 2004, Pages 544-551

  Fazio, V M ^a,e   Ria, F ^b   Franco, E ^c   Rosati, P ^b   Cannelli, G ^b   Signori, E ^a,d   Parrella, P ^e   Zaratti, L ^c   Iannace, E ^b   Monego, G ^b   Blogna, S ^a   Fioretti, D ^d,e   Iurescia, S ^d,e   Filippetti, R ^b   Rinaldi, M ^d  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d Sezione Medicina Molecolare   (Italy)

^e CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

DNA vaccine technology; In utero vaccination; Infectious diseases; Intramuscular injection; Neonatal immunity; Nonviral vectors

Indexed keywords

DNA VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; NAKED DNA; PLASMID DNA; PLASMID VECTOR; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BREAST FEEDING; CONTROLLED STUDY; DELIVERY; DRUG EFFICACY; FETUS; FETUS MALFORMATION; FETUS WASTAGE; FOLLOW UP; GESTATION PERIOD; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK PREGNANCY; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; SWINE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS IMMUNITY; VIRUS PATHOGENESIS;

ANIMALS; ANIMALS, NEWBORN; FEMALE; FETUS; GENE THERAPY; GESTATIONAL AGE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; IMMUNIZATION; INJECTIONS, INTRAMUSCULAR; MODELS, ANIMAL; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SWINE; VACCINES, DNA;

ANIMALIA; HEPATITIS B VIRUS; SUS SCROFA;

EID: 11144357608     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302179     Document Type: Article

References (45)

1. Zimmerman RK, Ruben FL, Ahwesh ER. Hepatitis B virus infection, hepatitis B vaccine, and hepatitis B immune globulin. J Fam Pract 1997; 45: 295-315.
2. Baker DA. Issues and management of herpes in pregnancy. Int J Fertil Womens Med 2002; 47: 129-135.
3. Ahdieh L. Pregnancy and infection with human immunodeficiency virus. Clin Obstet Gynecol 2001; 44: 154-166.
4. Berner R. Group B streptococci during pregnancy and infancy. Curr Opin Infect Dis 2002; 15: 307-313.
5. Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002; 15: 680-715.
6. Aujard Y, Fauroux B. Risk factors for severe respiratory syncytial virus infection in infants. Respir Med 2002; 96 (Suppl B): S9-S14.
7. Syrjanen S, Puranen M. Human papillomavirus infections in children: The potential role of maternal transmission. Crit Rev Oral Biol Med 2000; 11: 259-274.
8. Wright PF, Wright PF. Infectious diseases in early life in industrialized countries. Vaccine 1998; 16: 1355-1359.
9. Towers CV, Asrat T, Rumney P. The presence of hepatitis B surface antigen and deoxyribonucleic acid in amniotic fluid and cord blood. Am J Obstet Gynecol 2001; 184: 1514-1518.
10. Komatsu H et al. Sequence analysis of hepatitis B virus genomes from an infant with acute severe hepatitis and a hepatitis B e antigen-positive carrier mother. J Med Virol 2001; 65: 457-462.
11. Sterneck M et al. Neonatal fulminant hepatitis B: Structural and functional analysis of complete hepatitis B virus genomes from mother and infant. J Infect Dis 1998; 177: 1378-1381.
12. Prevention of perinatal hepatitis B through enhanced case management - Connecticut, 1994-95, and the United States, 1994. MMWR Morb Mortal Wkly Rep 1996; 45: 584-587.
13. Ranger-Rogez S, Alain S, Denis F. Hepatitis viruses: mother-to-child transmission. Pathol Biol (Paris) 2002; 50: 568-575.
14. Vranckx R, Alisjahbana A, Meheus A. Hepatitis B virus vaccination and antenatal transmission of HBV markers to neonates. J Viral Hepat 1999; 6: 135-139.
15. Siegrist CA. Neonatal and early life vaccinology. Vaccine 2001; 19: 3331-3346.
16. Gerdts V et al. Fetal immunization by a DNA vaccine delivered into the oral cavity. Nat Med 2000; 6: 929-932.
17. Prud'homme GJ et al. Immunotherapeutic gene transfer into muscle. Trends Immunol 2001; 22: 149-155.
18. Spiegelberg HL, Raz E. DNA-based approaches to the treatment of allergies. Curr Opin Mol Ther 2002; 4: 64-71.
19. Ashmore CR, Addis PB, Doerr L. Development of muscle fibers in the fetal pig. J Anim Sci 1973; 36: 1088-1093.
20. Swatland HJ, Cassens TG. Prenatal development, histochemistry and innervation of porcine muscle. J Anim Sci 1973; 36: 343-354.
21. Tlaskalova-Hogenova L et al. Development of immune responses in early pig ontogeny. Vet Immunol Immunopathol 1994; 43: 135-442.
22. West DJ, Calandra GB. Vaccine induced immunologic memory for hepatitis B surface antigen: Implications for policy on booster vaccination. Vaccine 1996; 14: 1019-1027.
23. del Canho R et al. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: Protective efficacy and long-term immunogenicity. Vaccine 1997; 15: 1624-1630.
24. Binns RM. Bone marrow and lymphoid cell injection of the pig foetus resulting in transplantation tolerance or immunity, and immunoglobulin production. Nature 1967; 214: 179-181.
25. Swain WE et al. Tolerability and immune responses in humans to a PowderJect DNA vaccine for hepatitis B. Dev Biol (Basel) 2000; 104: 115-119.
26. Davis HL, Michel ML, Whalen RG. DNA-based immunization for hepatitis B induces continuous secretion of antigen and high levels of circulating antibody. Hum Mol Genet 1993; 2: 1847-1851.
27. Gerdts V et al. Oral DNA vaccination in-utero induces mucosal immunity and immune memory in the neonate. J Immunol 2002; 168: 1877-1885.
28. Ichino M et al. Factors associated with the development of neonatal tolerance after the administration of a plasmid DNA vaccine. J Immunol 1999; 162: 3814-3818.
29. Randall GC. Changes in the concentrations of corticosteroids in the blood of fetal pigs and their dams during late gestation and labor. Biol Reprod 1983; 29: 1077-1084.
30. Fevre J. Maternal and fetal corticosteroids in the sow at the end of gestation. C R Acad Sci Hebd Seances Acad Sci D 1975; 281: 2009-2012.
31. Murphy BE. Human fetal serum cortisol levels related to gestational age: Evidence of a midgestational fall and a steep late gestational rise, independent of sex or mode of delivery. Am J Obstet Gynecol 1982; 144: 276-282.
32. Ishii KJ, Veiss WR, Klinman DM. Prevention of neonatal tolerance by a plasmid encoding granulocyte-macrophage colony stimulating factor. Vaccine 1999; 18: 703-710.
33. Rinaldi M et al. Safe fetal gene transfer by transuterine injection of naked DNA into pig muscle and localized perinatal expression of different transgenes. (submitted for publication).
34. Everett RSR, Gerrard DE, Grant AL. Factors affecting production of luciferase and epitope-tagged IGF-I in porcine muscle after DNA injection. J Endocrinol 2000; 166: 255-263.
35. Parker SE et al. Plasmid DNA malaria vaccine: Tissue distribution and safety studies in mice and rabbits. Hum Gene Ther 1999; 10: 741-758.
36. Le TP et al. Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers. Vaccine 2000; 18: 1893-1901.
37. Martin T et al. Plasmid DNA malaria vaccine: The potential for genomic integration after intramuscular injection. Hum Gene Ther 1999; 10: 759-768.
38. Davis HL, Millan CL, Watkins SC. Immune-mediated destruction of transected muscles fibers direct gene transfer with antigen-expressing plasmid DNA. Gene Therapy 1997; 4: 181-188.
39. Mor G et al. Do DNA vaccines induce autoimmune disease? Hum Gene Ther 1997; 8: 293-300.
40. Wang G et al. Ultrasound-guided gene transfer to hepatocytes in-utero. Fetal Diagn Ther 1998; 13: 197-205.
41. Resti M et al. Ten-year follow-up study of neonatal hepatitis B immunization: Are booster injections indicated? Vaccine 1997; 15: 1338-1340.
42. Watts AM et al. Fetal immunization of baboons induces a fetal-specific antibody response. Nat Med 1999; 5: 427-430.
43. Ciafrè SA et al. A plasmid family containing two different expression cassettes suitable for immunomodulation and genetic immunization. Plasmid 1998; 40: 84-89.
44. Rinaldi M et al. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by intramuscular injection of plasmid DNA. Gene Therapy 2000; 7: 1795-1801.
45. Alexander JM et al. Risk of hepatitis B transmission after amniocentesis in chronic hepatitis B carriers. Infect Dis Obstet Gynecol 1999; 7: 283-286.